Compliance with the Global CAPA program is mandated by 21 CFR Part 211.180/192 and 21 CFR Part 820.100, which govern records and reports of drug product failure investigations and quality system regulation for corrective and preventive action respectively.

Compliance is mandated by: 21 CFR Part 211.180/192: Records and reports of drug product failure investigations. 21 CFR Part 820.100: Quality System Regulation for Corrective and Preventive Action. Compliance is mandated by.

legacy import — synthesised from supporting_context_primary